Morningstar, Inc.

  • Market Cap: Small Cap
  • Industry: Capital Markets
  • ISIN: US6177001095
USD
216.94
-0.21 (-0.1%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Morningstar, Inc. stock-summary
stock-summary
Morningstar, Inc.
Capital Markets
Morningstar, Inc. is a provider of independent investment research in North America, Europe, Australia, and Asia. The Company focuses to create products that help investors reach their financial goals. It offers a range of data, software, research, and investment management offerings for financial advisors, asset managers, sponsors, and individual investors. It provides data and research insights on a range of investment offerings, including managed investment products, listed companies, capital markets, and real-time global market data. It conducts its business operations outside of the United States through subsidiaries in countries, including Australia, Brazil, Canada, Chile, Denmark, France, Germany, India, Italy, Japan, Luxembourg, Mexico, the Netherlands, New Zealand, Norway, People's Republic of China (both Hong Kong and the mainland), Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, the United Arab Emirates, and the United Kingdom.
Company Coordinates stock-summary
Company Details
22 W Washington St , CHICAGO IL : 60602-1605
stock-summary
Tel: 1 312 6966000
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 93 Schemes (31.6%)

Foreign Institutions

Held by 179 Foreign Institutions (8.53%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Joseph Mansueto
Executive Chairman of the Board
Mr. Kunal Kapoor
Chief Executive Officer, Director
Mr. Stephen Joynt
Director
Ms. Robin Diamonte
Independent Director
Ms. Cheryl Francis
Independent Director
Dr. Steven Kaplan
Independent Director
Ms. Gail Landis
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
605 Million
(Quarterly Results - Jun 2025)
Net Profit:
89 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 13,737 Million (Small Cap)

stock-summary
P/E

42.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

25.67%

stock-summary
Price to Book

8.51